{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:08:16Z","timestamp":1779455296084,"version":"3.53.1"},"reference-count":20,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Saudi Med"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>COVID-19 pandemic has caused a major global health disruption. Pediatric presentations vary widely, particularly among children with differing immune status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>To compare the clinical presentation, disease course, and outcomes of immunocompetent versus immunocompromised pediatric patients with COVID-19 in a tertiary referral hospital in Jeddah, Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>Retrospective chart review<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTINGS:<\/jats:title>\n                    <jats:p>A tertiary center treating immunocompromised children including those with HIV, solid and hematologic malignancies, and solid organ or hematopoietic stem cell transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS:<\/jats:title>\n                    <jats:p>\n                      Records of 123 pediatric patients (&lt;15 years) with confirmed COVID-19 from March 2020 to March 2021 were reviewed. Demographic, clinical, laboratory, radiologic, and treatment variables were extracted and compared between immunocompetent and immunocompromised patients. Chi-square testing was used with significance set at\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.05. Immunocompromised status was defined as the presence of an underlying medical condition or treatment associated with clinically significant immune suppression\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN OUTCOME MEASURES:<\/jats:title>\n                    <jats:p>Differences in symptoms, severity, clinical progression, and outcomes between immunocompetent and immunocompromised children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SAMPLE SIZE:<\/jats:title>\n                    <jats:p>123 children<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Most patients were immunocompetent (93, 75.6%). Immunocompromised children primarily included post-transplant or oncology patients on chemotherapy. Fever was the most common presenting symptom (69, 56.1%), significantly more common in immunocompetent children (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.029). Immunocompromised children were more frequently admitted, mainly for non-COVID-related concerns (e.g., abnormal chest radiograph, febrile neutropenia, or hydration). Nearly all patients recovered without complications, and no significant difference in recovery rate was observed between groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.568).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>COVID-19 severity and recovery appeared similar between immunocompetent and immunocompromised pediatric patients in this cohort. However, the higher hospitalization rate observed among immunocompromised children likely reflects precautionary admission practices rather than increased disease severity. Findings should be interpreted cautiously given the small immunocompromised subgroup and heterogeneity of underlying conditions. Interpretation of these findings is limited by the retrospective design and relatively small sample size. Larger multicenter studies are required to confirm these observations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5144\/0256-4947.2026.84","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T07:54:12Z","timestamp":1776585252000},"page":"84-93","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features and disease severity across immune status in pediatric patients with COVID-19"],"prefix":"10.5144","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-8852","authenticated-orcid":false,"given":"Nawaf Mohammed","family":"Al-Dajani","sequence":"first","affiliation":[{"name":"From the Pediatric Infectious Diseases, King Abdullah University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Ahmed","family":"Bahasan","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, King Faisal Specialist Hospital &amp; Research Centre - Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha Abdullah","family":"Alzubedy","sequence":"additional","affiliation":[{"name":"From the Scholarship and Training Department, King Faisal Specialist Hospital &amp; Research Centre - Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan Ahmed","family":"AlSahafi","sequence":"additional","affiliation":[{"name":"From the Department of Pulmonology, McMaster University, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ela Lutfallah","family":"Alturkistani","sequence":"additional","affiliation":[{"name":"From the Academic and Training Affairs, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada Saleh","family":"AlZahrani","sequence":"additional","affiliation":[{"name":"From the Research Laboratories, King Faisal Specialist Hospital &amp; Research Centre - Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3134","reference":[{"issue":"7","key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/aogs.13867","article-title":"Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies","volume":"99","author":"Zaigham M","year":"2020","unstructured":"Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99(7):823\u20139.","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"3","key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"e00488","DOI":"10.34172\/jrhs.2020.22","article-title":"Evaluating Clinical Course and Risk Factors of Infection and Demographic Characteristics of Pregnant Women with COVID-19 in Hamadan Province, West of Iran","volume":"20","author":"Sattari M","year":"2020","unstructured":"Sattari M, Bashirian S, Masoumi SZ, Shayan A, Jenabi E, Ghelichkhani S, et al. Evaluating Clinical Course and Risk Factors of Infection and Demographic Characteristics of Pregnant Women with COVID-19 in Hamadan Province, West of Iran. J Res Health Sci. 2020;20(3):e00488.","journal-title":"J Res Health Sci."},{"issue":"6","key":"e_1_3_2_4_2","article-title":"COVID-19 in Children: Initial Characterization of the Pediatric Disease","volume":"145","author":"Cruz AT","year":"2020","unstructured":"Cruz AT, Zeichner SL. COVID-19 in Children: Initial Characterization of the Pediatric Disease. Pediatrics. 2020;145(6).","journal-title":"Pediatrics."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"100433","DOI":"10.1016\/j.eclinm.2020.100433","article-title":"COVID-19 in 7780 pediatric patients: A systematic review","volume":"24","author":"Hoang A","year":"2020","unstructured":"Hoang A, Chorath K, Moreira A, Evans M, Burmeister-Morton F, Burmeister F, et al. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020;24:100433.","journal-title":"EClinicalMedicine."},{"issue":"1","key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12887-020-02140-7","article-title":"Chest CT imaging characteristics of COVID-19 pneumonia in preschool children: a retrospective study","volume":"20","author":"Li Y","year":"2020","unstructured":"Li Y, Cao J, Zhang X, Liu G, Wu X, Wu B. Chest CT imaging characteristics of COVID-19 pneumonia in preschool children: a retrospective study. BMC Pediatr. 2020;20(1):227.","journal-title":"BMC Pediatr."},{"issue":"2","key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3934\/publichealth.2020022","article-title":"Clinical Characteristics of Children with COVID-19","volume":"7","author":"Tung Ho CL","year":"2020","unstructured":"Tung Ho CL, Oligbu P, Ojubolamo O, Pervaiz M, Oligbu G. Clinical Characteristics of Children with COVID-19. AIMS Public Health. 2020;7(2):258\u201373.","journal-title":"AIMS Public Health."},{"issue":"1","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-020-01596-9","article-title":"A single-center, retrospective study of COVID-19 features in children: a descriptive investigation","volume":"18","author":"Ma H","year":"2020","unstructured":"Ma H, Hu J, Tian J, Zhou X, Li H, Laws MT, et al. A single-center, retrospective study of COVID-19 features in children: a descriptive investigation. BMC Med. 2020;18(1):123.","journal-title":"BMC Med."},{"issue":"10","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"e202430","DOI":"10.1001\/jamapediatrics.2020.2430","article-title":"Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children\u2019s Hospital in New York City, New York","volume":"174","author":"Zachariah P","year":"2020","unstructured":"Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI, Fischer A, et al. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children\u2019s Hospital in New York City, New York. JAMA Pediatr. 2020;174(10):e202430.","journal-title":"JAMA Pediatr."},{"issue":"12","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"e28745","DOI":"10.1002\/pbc.28745","article-title":"Hematological manifestations of SARS-CoV-2 in children","volume":"67","author":"Kosmeri C","year":"2020","unstructured":"Kosmeri C, Koumpis E, Tsabouri S, Siomou E, Makis A. Hematological manifestations of SARS-CoV-2 in children. Pediatr Blood Cancer. 2020;67(12):e28745.","journal-title":"Pediatr Blood Cancer."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ijid.2020.04.090","article-title":"From SARS to COVID-19: What we have learned about children infected with COVID-19","volume":"96","author":"Zhou MY","year":"2020","unstructured":"Zhou MY, Xie XL, Peng YG, Wu MJ, Deng XZ, Wu Y, et al. From SARS to COVID-19: What we have learned about children infected with COVID-19. Int J Infect Dis. 2020;96:710\u20134.","journal-title":"Int J Infect Dis."},{"issue":"3","key":"e_1_3_2_12_2","first-page":"7","article-title":"Pediatric COVID-19 patients in Jeddah, Saudi Arabia: Clinical, laboratory and radiological aspects","volume":"9","author":"Al Harbi S","year":"2020","unstructured":"Al Harbi S, Kobeisy SAN, Mehdawi RS, Bashammakh DS, Mosalli RM. Pediatric COVID-19 patients in Jeddah, Saudi Arabia: Clinical, laboratory and radiological aspects. J Biomedical Sci. 2020;9(3):7.","journal-title":"J Biomedical Sci."},{"issue":"4","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.15537\/smj.2021.42.4.20210011","article-title":"Clinical characteristics and outcomes of children with COVID-19 in Saudi Arabia","volume":"42","author":"Alnajjar AA","year":"2021","unstructured":"Alnajjar AA, Dohain AM, Abdelmohsen GA, Alahmadi TS, Zaher ZF, Abdelgalil AA. Clinical characteristics and outcomes of children with COVID-19 in Saudi Arabia. Saudi Med J. 2021;42(4):391\u20138.","journal-title":"Saudi Med J."},{"issue":"4","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jiph.2020.12.034","article-title":"SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia","volume":"14","author":"Alharbi M","year":"2021","unstructured":"Alharbi M, Kazzaz YM, Hameed T, Alqanatish J, Alkhalaf H, Alsadoon A, et al. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia. J Infect Public Health. 2021;14(4):446\u201353.","journal-title":"J Infect Public Health."},{"issue":"4","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jiph.2021.01.011","article-title":"Coronavirus disease in children: A multicentre study from the Kingdom of Saudi Arabia","volume":"14","author":"Kari JA","year":"2021","unstructured":"Kari JA, Shalaby MA, Albanna AS, Alahmadi TS, Sukkar SA, MohamedNur HAH, et al. Coronavirus disease in children: A multicentre study from the Kingdom of Saudi Arabia. J Infect Public Health. 2021;14(4):543\u20139.","journal-title":"J Infect Public Health."},{"issue":"1","key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12887-021-02959-8","article-title":"Epidemiology, clinical characteristics and risk factors of COVID-19 among children in Saudi Arabia: a multicenter chart review study","volume":"22","author":"AlGhamdi A","year":"2022","unstructured":"AlGhamdi A, Al Talhi Y, Al Najjar A, Sobhi A, Al Juaid A, Ibrahim A, et al. Epidemiology, clinical characteristics and risk factors of COVID-19 among children in Saudi Arabia: a multicenter chart review study. BMC Pediatr. 2022;22(1):86.","journal-title":"BMC Pediatr"},{"issue":"3","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.15537\/smj.2021.42.3.20200625","article-title":"COVID-19 in children ranging from asymptomatic to a multi-system inflammatory disease: A single-center study","volume":"42","author":"Shahin W","year":"2021","unstructured":"Shahin W, Rabie W, Alyossof O, Alasiri M, Alfaki M, Mahmoud E, et al. COVID-19 in children ranging from asymptomatic to a multi-system inflammatory disease: A single-center study. Saudi Med J. 2021;42(3):299\u2013305.","journal-title":"Saudi Med J."},{"issue":"5","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/INF.0000000000002660","article-title":"Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children","volume":"39","author":"Zimmermann P","year":"2020","unstructured":"Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect Dis J. 2020;39(5):355\u201368.","journal-title":"Pediatr Infect Dis J."},{"issue":"2","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/idr13020029","article-title":"COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?","volume":"13","author":"Jirjees F","year":"2021","unstructured":"Jirjees F, Saad AK, Al Hano Z, Hatahet T, Al Obaidi H, Dallal Bashi YH. COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?. Infect Dis Rep. 2021;13(2):259\u201384.","journal-title":"Infect Dis Rep."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in children","volume":"383","author":"Feldstein LR","year":"2020","unstructured":"Feldstein LR et al. Multisystem inflammatory syndrome in children. N Engl J Med. 2020;383:334\u2013346.","journal-title":"N Engl J Med."},{"key":"e_1_3_2_21_2","first-page":"1022","article-title":"Long COVID in children","volume":"57","author":"Buonsenso D","year":"2022","unstructured":"Buonsenso D et al. Long COVID in children. Pediatr Pulmonol. 2022;57:1022\u20131025.","journal-title":"Pediatr Pulmonol."}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:37:53Z","timestamp":1779453473000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2026.84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.5144\/0256-4947.2026.84"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2026.84","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}